45,190 of the 145,652 total CD8+ NSCLC TIL (37.21% of all CD8+ NSCLC TIL profiled) were termed ‘putative tumor-reactive cells’ pTRC because they shared a TCR with at least 5 MANAscorehi TIL. This evidence concerns the gene CD8A and neoplasm.